MatthewEmeryHardeeMD

PubMed

• 22 citations
  Application of Spatially Fractionated Radiation (GRID) to Helical Tomotherapy using a Novel TOMOGRID Template
  X Zhang, Jose Penagaricano, Yulong Yan, Sunil K. Sharma, Robert J. Griffin, Matthew E. Hardee, Eun Young Han, V. Ratanatharathom> ;Technology in Cancer Research & Treatment. 2016 Feb 1
• 22 citations
  Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans
  X Liang, Jose Penagaricano, Dandan Zheng, Steven M. Morrill, X Zhang, Peter M. Corry, Robert J. Griffin, Eun Young Han, Matthew E. Hardee, V. Ratanatharathom> ;Radiation Oncology. 2016 Jan 22
• 7 citations
  A case of cutaneous Rosai-Dorfman disease (CRDD) with underlying calvarial involvement and absence of BRAFV600E mutation
  Nadine M. Kaskas, Malan Kern, Andrew Johnson, Matthew Hughes, Matthew E. Hardee, John D. Day, Murat Gokden, Sara C. Shalin, Ling Gao> ;JAAD Case Reports. 2015 Nov 1
• 39 citations
  Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.
  Nathan A. Koonce, Charles M. Quick, Matthew E. Hardee, Azemat Jamshidi-Parsian, Judith A. Dent, Giulio F. Paciotti, Dmitry A. Nedosekin, Ruud P.M. Dings, Robert J. Gri...> ;International Journal of Radiation Oncology, Biology, Physics. 2015 Nov 1
• 2 citations
  Dosimetric effect on pediatric conformal treatment plans using dynamic jaw with Tomotherapy HDA
  Eun Young Han, Dong Wook Kim, X Zhang, Jose Penagaricano, X Liang, Matthew E. Hardee, Steve Morrill, Vaneerat Ratanatharathorn> ;Medical Dosimetry. 2015 Sep 1
• 11 citations
  Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia.
  Nathan A. Koonce, Joseph W. Levy, Matthew E. Hardee, Azemat Jamshidi-Parsian, Kieng B. Vang, Sunil K. Sharma, James A. Raleigh, Ruud P.M. Dings, Robert J. Griffin> ;Plos One. 2015 Aug 26
• 7 citations
  Dosimetric Comparison of Craniospinal Irradiation Using Different Tomotherapy Techniques.
  X Zhang, Jose Penagaricano, Eun Young Han, Steven M. Morrill, Matthew E. Hardee, X Liang, S. K. Gupta, Peter M. Corry, V. Ratanatharathom> ;Technology in Cancer Research & Treatment. 2015 Aug 1
• 8 citations
  Development of a novel multiplexed assay for quantification of transforming growth factor-β (TGF-β)
  Ilenia Pellicciotta, Ariel E. Marciscano, Matthew E. Hardee, Derek Francis, Silvia C. Formenti, Mary Helen Barcellos-Hoff> ;Growth Factors. 2015 May 14
• 5 citations
  Long-Term Results of Phase II Ablation after Breast Lumpectomy Added to Extend Intraoperative Margins (ABLATE l) Trial
  V. Suzanne Klimberg, Daniela Ochoa, Ronda Henry-Tillman, Matthew E. Hardee, Cristiano Boneti, Laura Adkins, Maureen McCarthy, Evan Tummel, Jeannette Y. Lee, Sharp F. M...> ;Journal of the American College of Surgeons. 2014 Apr 1
• 76 citations
  Merkel Cell Carcinoma: Epidemiology, Target, and Therapy
  Mathew P. Hughes, Matthew E. Hardee, Lynn A. Cornelius, Laura F. Hutchins, Jürgen C. Becker, Ling Gao> ;Current Dermatology Reports. 2014 Jan 22
• 87 citations
  Nipple skin-sparing mastectomy is feasible for advanced disease.
  Eric C. Burdge, James C. Yuen, Matthew E. Hardee, Pranjali V. Gadgil, Chandan Das, Ronda Henry-Tillman, Daniela Ochoa, Soheila Korourian, V. Suzanne Klimberg> ;Annals of Surgical Oncology. 2013 Aug 22
• 305 citations
  Mechanisms of Glioma-Associated Neovascularization
  Matthew E. Hardee, David Zagzag> ;The American Journal of Pathology. 2012 Oct 1
• 178 citations
  Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β
  Matthew E. Hardee, Ariel E. Marciscano, Christina M. Medina-Ramirez, David Zagzag, Ashwatha Narayana, Scott Lonning, Mary Helen Barcellos-Hoff> ;Cancer Research. 2012 Aug 15
• 3 citations
  Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomide
  Matthew E. Hardee, Silvia C. Formenti> ;Frontiers in Oncology. 2012 Aug 9
• 35 citations
  Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique.
  Matthew E. Hardee, Shahzad Raza, Stewart J. Becker, Gabor Jozsef, Stella C. Lymberis, Tsivia Hochman, Judith D. Goldberg, K. DeWyngaert, Silvia C. Formenti> ;International Journal of Radiation Oncology, Biology, Physics. 2012 Mar 1
• 39 citations
  Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification
  Allison S. Betof, Zahid N. Rabbani, Matthew E. Hardee, Sua Kim, Gloria Broadwater, Rex C. Bentley, Stacey A. Snyder, Zeljko Vujaskovic, Egbert Oosterwijk, Lyndsay Harr...> ;British Journal of Cancer. 2012 Feb 28
• 13 citations
  Management of High-Risk Localized Prostate Cancer
  Ariel E. Marciscano, Matthew E. Hardee, Nicholas J. Sanfilippo> ;Advances in Urology. 2012 Jan 1
• 4 citations
  Review of chemoradiotherapy for high-risk prostate cancer.
  Nicholas J. Sanfilippo, Matthew E. Hardee, Jonathan B. Wallach> ;Reviews on Recent Clinical Trials. 2011 Jan 1
• 15 citations
  Squamous cell carcinoma of the prostate.
  Rena D. Malik, George Dakwar, Matthew E. Hardee, Nicholas J. Sanfilippo, Andrew B. Rosenkrantz, Samir S. Taneja> ;Reviews in Urology. 2011 Jan 1
• 35 citations
  Novel Imaging Provides New Insights into Mechanisms of Oxygen Transport in Tumors
  Matthew E. Hardee, Mark W. Dewhirst, Nikita Agarwal, Brian S. Sorg> ;Current Molecular Medicine. 2009 May 1
• 18 citations
  Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors
  Matthew E. Hardee, Rose J. Eapen, Zahid N. Rabbani, Matthew R. Dreher, Jeffrey R. Marks, Kimberly L. Blackwell, Mark W. Dewhirst> ;Cancer Chemotherapy and Pharmacology. 2009 Jan 1
• 31 citations
  Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors.
  Brian S. Sorg, Matthew E. Hardee, Nikita Agarwal, Benjamin J. Moeller, Mark W. Dewhirst> ;Journal of Biomedical Optics. 2008 Jan 1
• 82 citations
  Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression
  Matthew E. Hardee, Yiting Cao, Ping Fu, Xiaohong Jiang, Yulin Zhao, Zahid N. Rabbani, Zeljko Vujaskovic, Mark W. Dewhirst, Murat O. Arcasoy> ;Plos One. 2007 Jun 20
• 10 citations
  The Effect of Darbepoetin Alfa on Growth, Oxygenation and Radioresponsiveness of a Breast Adenocarcinoma
  John P. Kirkpatrick, Matthew E. Hardee, Stacey A. Snyder, Catherine M. Peltz, Yulin Zhao, David M. Brizel, Mark W. Dewhirst, Kimberly L. Blackwell> ;Radiation Research. 2006 Feb 1
• 51 citations
  Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity.
  Matthew E. Hardee, Zahid N. Rabbani, Murat O. Arcasoy, John P. Kirkpatrick, Zeljko Vujaskovic, Mark W. Dewhirst, Kimberly L. Blackwell> ;Molecular Cancer Therapeutics. 2006 Feb 1
• Join now to see all